Cargando…

Response to BNT162b2 mRNA COVID-19 vaccine among healthcare workers in Italy: a 3-month follow-up—Reply

Detalles Bibliográficos
Autores principales:	Ferrara, Pietro, Antonazzo, Ippazio C., Polosa, Riccardo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Ce - Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8744061/ https://www.ncbi.nlm.nih.gov/pubmed/35006537 http://dx.doi.org/10.1007/s11739-021-02911-9

Ejemplares similares

Response to BNT162b2 mRNA COVID-19 vaccine among healthcare workers in Italy: a 3-month follow-up
por: Ponticelli, Domenico, et al.
Publicado: (2021)

Response to BNT162b2 mRNA COVID-19 vaccine among healthcare workers in Italy: a 3-month follow-up: comment
por: Serraino, Cristina, et al.
Publicado: (2022)

A double-edged sword: e-cigarettes, and other electronic nicotine delivery systems (ENDS): reply
por: Polosa, Riccardo, et al.
Publicado: (2019)

COVID-19: counter-intuitive data on smoking prevalence and therapeutic implications for nicotine
por: Polosa, Riccardo, et al.
Publicado: (2020)

SARS-CoV-2 antibody response after BNT162b2 mRNA vaccine in healthcare workers: Nine-month of follow-up
por: Mastroianni, Franco, et al.
Publicado: (2022)

E-cigarettes and smoking cessation: a critique of a New England Journal Medicine-commissioned case study
por: Polosa, Riccardo, et al.
Publicado: (2016)

Early Serological Response to BNT162b2 mRNA Vaccine in Healthcare Workers
por: Cocomazzi, Giovanna, et al.
Publicado: (2021)

A scoping review of studies on the health impact of electronic nicotine delivery systems
por: Hajat, Cother, et al.
Publicado: (2021)

Telemedicine in Italy, the starting point
por: Parretti, Chiara, et al.
Publicado: (2022)

Patient Perspective, Complexities, and Challenges in Managed Care
por: Jan, Saira
Publicado: (2010)

Atrial Fibrillation and Managed Care: Current Approaches and Future Directions for Long-Term Therapy
por: Sanoski, Cynthia A., et al.
Publicado: (2009)

Effectiveness of the BNT162b2 mRNA Covid-19 vaccine in Spanish healthcare workers
por: Núñez López, Concepción, et al.
Publicado: (2023)

Effectiveness of the BNT162b2 mRNA Covid-19 vaccine in Spanish healthcare workers
por: Núñez López, Concepción, et al.
Publicado: (2023)

Three-month analysis of total humoral response to Pfizer BNT162b2 mRNA COVID-19 vaccination in healthcare workers
por: Salvagno, Gian Luca, et al.
Publicado: (2021)

Decreasing humoral response among healthcare workers up to 4 months after two doses of BNT162b2 vaccine
por: Ferré, Valentine Marie, et al.
Publicado: (2022)

Editorial: Overcoming boundaries in public health: Advances in international and global health
por: Antonazzo, Ippazio C., et al.
Publicado: (2022)

BNT162b2 COVID-19 Vaccine Safety among Healthcare Workers of a Tertiary Hospital in Italy
por: Beccia, Flavia, et al.
Publicado: (2023)

Are we on brink of a second COVID-19 wave in Italy? Let’s look at Google Trends
por: Ciaffi, Jacopo, et al.
Publicado: (2020)

Eight-Month Follow-up After the Third Dose of BNT162b2 Vaccine in Healthcare Workers: The Question of a Fourth Dose
por: Lim, Sung Hee, et al.
Publicado: (2023)

Persistence of Anti-S Titre among Healthcare Workers Vaccinated with BNT162b2 mRNA COVID-19
por: Coppeta, Luca, et al.
Publicado: (2021)

Effectiveness of BNT162b2 COVID-19 vaccine among healthcare workers of a large hospital, Milan, Italy
por: Consonni, Dario, et al.
Publicado: (2022)

Humoral and Cellular Response and Associated Variables Nine Months following BNT162b2 Vaccination in Healthcare Workers
por: Syrimi, Natalia, et al.
Publicado: (2023)

Short-Term Safety of Booster Immunization With BNT162b2 mRNA COVID-19 Vaccine in Healthcare Workers
por: Paran, Yael, et al.
Publicado: (2021)

Adverse Reactions of the Second Dose of the BNT162b2 mRNA COVID-19 Vaccine in Healthcare Workers in Korea
por: Lee, Yun Woo, et al.
Publicado: (2021)

Antibody response to third and fourth BNT162b2 mRNA booster vaccinations in healthcare workers in Tokyo, Japan
por: Sanada, Takahiro, et al.
Publicado: (2023)

Delirium in COVID‑19 pneumonia: looking inside the geriatric unit—reply
por: Callea, Antonio, et al.
Publicado: (2022)

Waning of IgG, Total and Neutralizing Antibodies 6 Months Post-Vaccination with BNT162b2 in Healthcare Workers
por: Bayart, Jean-Louis, et al.
Publicado: (2021)

Immunogenicity trends 1 and 3 months after second BNT162B2 vaccination among healthcare workers in Israel
por: Shachor-Meyouhas, Yael, et al.
Publicado: (2022)

Antibody titers among healthcare workers for coronavirus disease 2019 at 6 months after BNT162b2 vaccination
por: Kurashima, Kazuyoshi, et al.
Publicado: (2022)

Immunogenicity evaluation after BNT162b2 booster vaccination in healthcare workers
por: Zurac, Sabina, et al.
Publicado: (2022)

Effectiveness of the BNT162b2 and the CoronaVac vaccines and boosters in healthcare workers
por: Çulpan, Hazal Cansu, et al.
Publicado: (2023)

Bilateral lower limb weakness: a cerebrovascular consequence of covid-19 or a complication associated with it?
por: Morjaria, J. B., et al.
Publicado: (2020)

IgG anti-RBD levels during 8-month follow-up post-vaccination with BNT162b2 and mRNA-1273 vaccines in healthcare workers: A one-center study
por: Gil-Manso, Sergio, et al.
Publicado: (2022)

Google trends and COVID-19 in Italy: could we brace for impact?
por: Ciaffi, Jacopo, et al.
Publicado: (2020)

Induction of immune response after SARS-CoV-2 mRNA BNT162b2 vaccination in healthcare workers
por: Zaffina, Salvatore, et al.
Publicado: (2021)

Antibody responses to BNT162b2 mRNA COVID-19 vaccine in healthcare workers and patients with urological diseases in Japan
por: Hatakeyama, S., et al.
Publicado: (2022)

Antibody response to BNT162b2 mRNA vaccine in healthcare workers and residents in a long‐term care facility
por: Kitagawa, Takao, et al.
Publicado: (2022)

IgG anti-spike antibody levels in healthcare workers with and without prior COVID-19 up to 3 months after BNT162b2 vaccination
por: Van Elslande, Jan, et al.
Publicado: (2022)

Blood ozonization in patients with mild to moderate COVID-19 pneumonia: a single centre experience: reply
por: De Monte, Amato, et al.
Publicado: (2021)

Impact of prior infection status on antibody response to the BNT162b2 mRNA COVID-19 vaccine in healthcare workers at a COVID-19 referral hospital in Milan, Italy
por: Milazzo, Laura, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1cush0vm07i99khlhfk2h71g1g